News

Statement of Robert K. Coughlin President & CEO of MassBio on the Passage of H.R. 3 December 13, 2019 in Announcements

Members of the House who voted to pass H.R. 3 are now on record as supporting fewer new medicines coming to the market each year. Read More

Statement by MassBio President & CEO Robert K. Coughlin on the USMCA Compromise Bill December 12, 2019 in Policy Updates

The removal of enhanced IP protections for biologic medicines in the revised USMCA promises to jeopardize this ingenuity, opening the door for foreign free-riding on American medical innovation Read More

Statement by MassBio President & CEO Robert K. Coughlin on the Senate Drug Pricing Bill November 7, 2019 in Policy Updates

Legislative solutions already exist to ensure patient access to prescription drugs – solutions that aren’t arbitrary and punitive Read More

MassBio’s Annual Patient Advocacy Summit to Debate Value Equation & Challenges to Patient Access October 29, 2019 in Announcements

Interested media can register for MassBio's annual Patient Advocacy Summit for free by contacting Jennifer Nason. Read More

Statement by MassBio President & CEO Robert K. Coughlin on Gov. Baker Healthcare Bill October 18, 2019 in Policy Updates

Healthcare reform should be designed to reduce costs for consumers. The Administration’s proposal misses the mark by not including any proposals that would directly control... Read More

MassBio® Announces the MassBioHub, a New Conference and Business Center for Members October 16, 2019 in Announcements

MassBio today announced that it will open a new conference and business center in Kendall Square, the MassBioHub, exclusively for its members. Read More

MassBio® Welcomes Four Life Sciences and Digital Health Startups to Participate in Final 2019 MassCONNECT® Mentorship Cycle October 3, 2019 in Announcements

MassBio’s MassCONNECT yesterday kicked off its third and final cycle of 2019 with a technology showcas Read More

Statement by MassBio President & CEO Robert K. Coughlin on Preliminary Mass HPC Study on Prescription Drug Coupons October 2, 2019 in Policy Updates

"The findings in the Health Policy Commission’s (HPC) preliminary report on prescription drug coupons are clear: coupons improve patient access to breakthrough therapies" Read More

MassBio’s 2019 Transportation Survey Finds 60% of Respondents Would Change Jobs for a Better Commute September 25, 2019 in Announcements

MassBio today released a report on the state of transportation in Massachusetts, detailing the results of a survey of 2,133 professionals who work in or support the life sciences. Read More

BioCT Joins MassBio’s Member Savings Program, New England Edge, to Support Life Sciences Industry Growth Throughout the Region September 12, 2019 in Announcements

MassBio today announced a new partnership with BioCT to expand access to MassBio’s member savings program, MassBio Edge, to BioCT members. Read More